Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytokinetics (CYTK) Buildings: 2009-2010

  • Cytokinetics' Buildings rose 0.61% to $3.3 million in Q4 2010 from the same period last year, while for Dec 2010 it was $3.3 million, marking a year-over-year increase of 0.61%. This contributed to the annual value of $3.3 million for FY2010, which is 0.61% up from last year.
  • Cytokinetics' Buildings amounted to $3.3 million in Q4 2010, which was up 0.61% from $3.3 million recorded in Q4 2009.
  • In the past 5 years, Cytokinetics' Buildings registered a high of $3.3 million during Q4 2010, and its lowest value of $3.3 million during Q4 2009.
  • Over the past 2 years, Cytokinetics' median Buildings value was $3.3 million (recorded in 2009), while the average stood at $3.3 million.
  • Data for Cytokinetics' Buildings shows a peak YoY increased of 0.61% (in 2010) over the last 5 years.
  • Over the past 2 years, Cytokinetics' Buildings (Quarterly) stood at $3.3 million in 2009, then increased by 0.61% to $3.3 million in 2010.